mapping the effectiveness and risks of glp-1 receptor agonists - Nature Medicine mapping the effectiveness and risks

(Total CEA in a tablet = 200 CEA)

PHM27) Pituitary adenylate cyclase activating peptide (PACAP) Peptide PHI 27 (peptide histidine isoleucine 27) Growth hormone releasing hormone (GHRH) 1-24 Glucagon Secretin Pancreatic polypeptide-related peptides [edit source] Neuropeptide Y (NPY) Peptide YY (PYY) Avian pancreatic polypeptide (APP) Pancreatic polypeptide (PPY) Opioid peptides [edit source] Proopiomelanocortin (POMC) peptides Enkephalin pentapeptides Prodynorphin peptides Calcitonin peptides [edit source] Self-assembling peptides [edit source] Other peptides [edit source] B-type Natriuretic Peptide (BNP) produced in the myocardium and useful in medical diagnosis Lactotripeptides Lactotripeptides might reduce blood pressure, [41] [42] [43] although the evidence is mixed

doi: 10.1046/j.1471-4159.1999.0722092.x

Myth 3: Treatment Is Permanent Reality: Maintenance and lifestyle habits influence long-term outcomes